These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33658228)

  • 41. A clinical study evaluating the combination of LISA and SNIPPV for the treatment of respiratory distress syndrome in preterm infants.
    Permall DL; Zhang Y; Li H; Guan Y; Chen X
    Sci Rep; 2024 Jan; 14(1):1429. PubMed ID: 38228632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Continuous positive airway pressure failure in preterm infants: incidence, predictors and consequences.
    Dargaville PA; Aiyappan A; De Paoli AG; Dalton RG; Kuschel CA; Kamlin CO; Orsini F; Carlin JB; Davis PG
    Neonatology; 2013; 104(1):8-14. PubMed ID: 23595061
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prophylactic versus Early Rescue Surfactant Treatment in Preterm Infants Born at Less than 30 Weeks Gestation or with Birth Weight Less than or Equal 1,250 Grams.
    Chun J; Sung SI; Ho YH; Kim J; Park GY; Yoon SA; Ahn SY; Chang YS; Park WS
    J Korean Med Sci; 2017 Aug; 32(8):1288-1294. PubMed ID: 28665065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nasal CPAP or intubation at birth for very preterm infants.
    Morley CJ; Davis PG; Doyle LW; Brion LP; Hascoet JM; Carlin JB;
    N Engl J Med; 2008 Feb; 358(7):700-8. PubMed ID: 18272893
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-invasive versus invasive respiratory support in preterm infants.
    Manley BJ; Cripps E; Dargaville PA
    Semin Perinatol; 2024 Mar; 48(2):151885. PubMed ID: 38570268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Noninvasive Support: Does It Really Decrease Bronchopulmonary Dysplasia?
    Wright CJ; Polin RA
    Clin Perinatol; 2016 Dec; 43(4):783-798. PubMed ID: 27837759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes following less-invasive-surfactant-administration in the delivery-room.
    Arattu Thodika FMS; Ambulkar H; Williams E; Bhat R; Dassios T; Greenough A
    Early Hum Dev; 2022 Apr; 167():105562. PubMed ID: 35245828
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Less Invasive Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome.
    Halim A; Shirazi H; Riaz S; Gul SS; Ali W
    J Coll Physicians Surg Pak; 2019 Mar; 29(3):226-330. PubMed ID: 30823947
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation.
    Dargaville PA; Kamlin CO; De Paoli AG; Carlin JB; Orsini F; Soll RF; Davis PG
    BMC Pediatr; 2014 Aug; 14():213. PubMed ID: 25164872
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surfactant delivery strategies to prevent bronchopulmonary dysplasia.
    Kribs A; Roberts KD; Trevisanuto D; O'Donnell C; Dargaville PA
    Semin Perinatol; 2023 Oct; 47(6):151813. PubMed ID: 37805275
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early CPAP versus surfactant in extremely preterm infants.
    ; Finer NN; Carlo WA; Walsh MC; Rich W; Gantz MG; Laptook AR; Yoder BA; Faix RG; Das A; Poole WK; Donovan EF; Newman NS; Ambalavanan N; Frantz ID; Buchter S; Sánchez PJ; Kennedy KA; Laroia N; Poindexter BB; Cotten CM; Van Meurs KP; Duara S; Narendran V; Sood BG; O'Shea TM; Bell EF; Bhandari V; Watterberg KL; Higgins RD
    N Engl J Med; 2010 May; 362(21):1970-9. PubMed ID: 20472939
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Less Invasive Surfactant Administration for the Treatment of Neonatal Respiratory Distress Syndrome Combined With Noninvasive Ventilation in Anhui Province, China: A Retrospective Cohort Study.
    Zhang X; Pan J; Zhu L; Ye Y; Fan Z; Chen X; Wang H; Wei G; Zhang L
    Clin Pediatr (Phila); 2023 Oct; 62(9):1109-1117. PubMed ID: 36748921
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of combined administration of surfactant and intratracheal budesonide compared to surfactant alone on bronchopulmonary dysplasia (BPD) and mortality rate in preterm infants with respiratory distress syndrome: a single-blind randomized clinical trial.
    Marzban A; Mokhtari S; Tavakkolian P; Mansouri R; Jafari N; Maleki A
    BMC Pediatr; 2024 Apr; 24(1):262. PubMed ID: 38643076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Less invasive surfactant administration (LISA): chances and limitations.
    Herting E; Härtel C; Göpel W
    Arch Dis Child Fetal Neonatal Ed; 2019 Nov; 104(6):F655-F659. PubMed ID: 31296694
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison of the effects of invasive mechanic ventilation/surfactant therapy and non-invasive nasal-continuous positive airway pressure in preterm newborns.
    Celik M; Bulbul A; Uslu S; Dursun M; Guran O; Kıray Bas E; Arslan S; Zubarioglu U
    J Matern Fetal Neonatal Med; 2018 Dec; 31(24):3225-3231. PubMed ID: 28856971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early nasal continuous positive airway pressure failure prediction in preterm infants less than 32 weeks gestational age suffering from respiratory distress syndrome.
    Dell'Orto V; Nobile S; Correani A; Marchionni P; Giretti I; Rondina C; Burattini I; Palazzi ML; Carnielli VP
    Pediatr Pulmonol; 2021 Dec; 56(12):3879-3886. PubMed ID: 34610212
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Less Invasive Surfactant Administration (LISA) Versus INSURE Method in Preterm Infants: a Retrospective Study.
    Dini G; Santini MG; Celi F
    Med Arch; 2024; 78(2):112-116. PubMed ID: 38566872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surfactant therapy in premature babies: SurE or InSurE.
    Jena SR; Bains HS; Pandita A; Verma A; Gupta V; Kallem VR; Abdullah M; Kawdiya A; On Behalf Of Sure Group
    Pediatr Pulmonol; 2019 Nov; 54(11):1747-1752. PubMed ID: 31424177
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surfactant administration in preterm babies (28-36 weeks) with respiratory distress syndrome: LISA versus InSurE, an open-label randomized controlled trial.
    Mishra A; Joshi A; Londhe A; Deshmukh L
    Pediatr Pulmonol; 2023 Mar; 58(3):738-745. PubMed ID: 36416036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.